Kadimastem Appoints Prof. Tamir Ben-Hur as a Member of the Company's Scientific Advisory Board Jan. 5, 2014 Kadimastem Augments the...

2 בינואר 2014 – חברת קדימהסטם, המפתחת טכנולוגיות לסריקת ופיתוח תרופות על בסיס תאי גזע מאדם, מחזקת את צמרת המדענים בחברה ומודיעה על מינויו...

Kadimastem has received approval from the OCS for a budget of NIS 8.5m to promote cell therapy and the research into drugs for diabetes...

Nov. 4, 2013 November 4, 2013 (Nes Ziona, Israel and Darmstadt, Germany) – Merck Serono, a leading global pharmaceutical company,  and...

Jun. 9, 2013 Nes Ziona, Israel, June 10, 2013 - Kadimastem Ltd. (TASE:KDST), focusing on the development and industrial commercialization...

Kadimastem will screen compounds of Merck Serono for potential new oral drugs to treat Multiple SclerosisNes Ziona, Israel, April 5, 2012...

Dr. Opper was the Chief Scientist of the Israeli Ministry of Industry, Trade and Labor for a period of 7 years. Previously he served as...

On January 18th , 2012 the Board of Directors of Kadimastem appointed Mr. Ofer Haviv as one of its directors. Mr. Haviv is the CEO of...

On June 13th , 2011 the Chief Scientist of the Ministry of Industry, Trade and Labor, Mr. Avi Hasson visited the facilities and...

Kadimastem is proud to report a visit by the Chief Scientist of the Ministry of Industry, Trade and Labor, Dr. Eli Opper. The Chief...